Health TrialsbyHealthPanel

Point of Care STI Testing

ConditionPoint of Care STI Testing
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-24
SponsorIcahn School of Medicine at Mount Sinai

About this trial

The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Gonorrhea/chlamydia Point-of-Care Testing

    Behavioral

    Point-of-care testing for sexually transmitted infections.

Treatment groups

6,460 Participants
are divided into 2 treatment groups
Group A: Point-of-Care TestedExperimental treatment 1 intervention
Group B: Lab TestedNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Rates of HIV Test Completion

Rates of HIV test completion on the day of gonorrhea/chlamydia testing will be compared between those who receive point-of-care vs. lab-based STI testing.

Time frame
Day 1 - Measured on date of STI testing

Secondary outcomes

1

Number of participants who received PrEP counseling

PrEP counseling will be measured using visit note data from the date of the STI testing encounter

Time frame
Day 1 - Same day as STI testing encounter
2

Time to STI treatment

Days between STI test order and delivery of antibiotics for STI treatment, measured using EHR data

Time frame
Time from STI diagnosis to treatment, up to 9 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Icahn School of Medicine at Mount Sinai

Lead sponsor

Children's Hospital of Philadelphia

Collaborator

Source ClinicalTrials.gov
Apply now